Author

Sidharth Mehan

ISF College of Pharmacy, Moga, Punjab, India

h-index 31 Homepage View on Semantic Scholar

We have 4 of 132 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jan 2026

GPCR-Driven Muscarinic M1 and Histamine H1 Receptor Signaling Converging on the PI3K/Akt/mTOR Pathway: Functional Integration in Neuroinflammation and Myelin Repair in Multiple Sclerosis

Rohit Kumar Singh, Janvi Verma, Sidharth Mehan et al. · Molecular Neurobiology · 0 citations

Review Aug 2026

Pentadecanoic Acid as a Potential Endogenous mTOR Modulator for Age-Related Female Infertility: Mechanistic Insights, Molecular Docking Evidence, and Therapeutic Perspectives.

R. Kalfin, Sidharth Mehan, Rajaram Samant et al. · Journal of Steroid Biochemis... · 0 citations

Aug 2026

Combined clemastine fumarate and selenomethionine promote remyelination via PI3K/Akt/mTOR signaling in experimental multiple sclerosis.

CMF and SLM appear to exert complementary neuroprotective and remyelinating effects, CMF principally promoting oligodendrocyte-mediated remyelination and SLM limiting oxidative and inflammatory injury that together converge on the PI3K/Akt/mTOR axis, supporting simultaneous dual-target intervention as a rational strate...

Rohit Kumar Singh, Sidharth Mehan · Naunyn-Schmiedeberg's Archiv... · 0 citations

#gene editing Review Open access Aug 2026

Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives.

Overall, despite existing challenges, neoantigen-targeted immunotherapies hold promise for advancing precision oncology and improving patient outcomes.

Aditya Raj, Zuber Khan, Mumtaz et al. · Immunotherapy · 0 citations